Total raised
$2.0M
Last: Undisclosed 2018-01
Stage
Seed
Founded
2015
Headcount
15
HQ
Ramat Gan
Sector
Health Tech & Life Sciences
About
Cytora is on a mission to make it standard practice for people to be treated with off-the-shelf (allogeneic) Stem Cell medicines, derived from the readily accessible oral mucosa termed human oral mucosa stem cells - hOMSC, for some of the toughest diseases within this decade, including Parkinson’s, Multiple System Atrophy (MSA), Alzheimer’s Dementia, and non-healing diabetic wounds (IDFU).
Cytora is a portfolio company of Galil Ofek Innovations, a peripheral technology incubator focused primarily on biomedical technologies such as medical devices.
Funding history · 1 round · $2.0M total
2018-01
Undisclosed
Undisclosed
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
alzheimers-diseasemedical-technologiestherapeuticspharma-companiesdiabetesulcerscell-therapystem-cellsregenerative-medicinebiotechnologyparkinson